(Q45122603)

English

Weekly docetaxel and cisplatin with concomitant radiotherapy in addition to surgery and/or consolidation chemotherapy in stage III non-small cell lung cancer

scientific article published on 17 April 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Weekly docetaxel and cisplatin with concomitant radiotherapy in addition to surgery and/or consolidation chemotherapy in stage III non-small cell lung cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

1 reference

based on heuristic

inferred from title

author name string

Fatma Sen

1

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Esra Kaytan Saglam

2

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Alper Toker

3

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Sukru Dilege

4

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Ahmet Kizir

5

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Ethem Nezih Oral

6

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Pinar Saip

7

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Barkin Sakallioglu

8

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Erkan Topuz

9

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Adnan Aydiner

10

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

publication date

17 April 2011

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Cancer Chemotherapy and Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

68

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

1497-1505

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

https://scigraph.springernature.com/pub.10.1007/s00280-011-1642-8

0 references

American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: update 2003.

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1642-8

21 January 2018

Recent advances in lung cancer: summary of presentations from the 45th annual meeting of the American Society of Clinical Oncology (2009).

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1642-8

21 January 2018

Third-generation chemotherapy agents in the treatment of advanced non-small cell lung cancer: a meta-analysis

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1642-8

21 January 2018

Concurrent chemoradiotherapy for unresectable stage III non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1642-8

21 January 2018

Combined modality therapy for stage III non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1642-8

21 January 2018

Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1642-8

21 January 2018

Randomized phase III trial of sequential chemoradiotherapy compared with concurrent chemoradiotherapy in locally advanced non-small-cell lung cancer: Groupe Lyon-Saint-Etienne d'Oncologie Thoracique-Groupe Français de Pneumo-Cancérologie NPC 95-01 S

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1642-8

21 January 2018

Concurrent versus sequential chemoradiotherapy with cisplatin and vinorelbine in locally advanced non-small cell lung cancer: a randomized study

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1642-8

21 January 2018

Concurrent two-dimensional radiotherapy and weekly docetaxel in the treatment of stage III non-small cell lung cancer: a good local response but no good survival due to radiation pneumonitis

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1642-8

21 January 2018

Cisplatin and weekly docetaxel with concurrent thoracic radiotherapy for locally advanced stage III non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1642-8

21 January 2018

Oral vinorelbine and cisplatin with concomitant radiotherapy in stage III non-small cell lung cancer (NSCLC): a feasibility study

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1642-8

21 January 2018

Concurrent chemoradiotherapy with cisplatin and vinorelbine for stage III non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1642-8

21 January 2018

Phase I/II study of weekly docetaxel dose escalation in combination with fixed weekly cisplatin and concurrent thoracic radiotherapy in locally advanced non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1642-8

21 January 2018

Concomitant weekly docetaxel, cisplatin and radiation therapy in locally advanced non-small cell lung cancer: a dose finding study

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1642-8

21 January 2018

Phase I/II study of docetaxel and cisplatin with concurrent thoracic radiation therapy for locally advanced non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1642-8

21 January 2018

Phase I study of weekly docetaxel and cisplatin concurrent with thoracic radiotherapy in Stage III non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1642-8

21 January 2018

Combined chemo-radiotherapy for locally advanced non-small cell lung cancer: current status and future development

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1642-8

21 January 2018

Consolidation Docetaxel After Concurrent Chemoradiotherapy in Stage IIIB Non–Small-Cell Lung Cancer: Phase II Southwest Oncology Group Study S9504

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1642-8

21 January 2018

Phase III study of cisplatin, etoposide, and concurrent chest radiation with or without consolidation docetaxel in patients with inoperable stage III non-small-cell lung cancer: the Hoosier Oncology Group and U.S. Oncology

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1642-8

21 January 2018

Concurrent chemoradiation therapy with docetaxel/cisplatin followed by docetaxel consolidation therapy in inoperable stage IIIA/B non-small-cell lung cancer: results of a phase I study

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1642-8

21 January 2018

Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1642-8

21 January 2018

Concomitant chemoradiotherapy with cisplatin and docetaxel followed by surgery and consolidation chemotherapy in patients with unresectable locally advanced non-small cell lung cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1642-8

21 January 2018

Multimodality treatment of stage III non-small cell lung cancer: analysis of a phase II trial using preoperative cisplatin and gemcitabine with concurrent radiotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1642-8

21 January 2018

Identifiers

10.1007/S00280-011-1642-8

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45122603&oldid=2066456468"